Real World Data Solutions Powered by Population Health Intelligence

The French Healthcare database SNDS: Access, Analysis, and Study Design

Certara is the first, non-academic applicant to be granted access to the French SNDS database of over 65 million lives with anonymized data on socio-demographics, medical characteristics, ambulatory care, hospitalizations, diagnosis, drugs and procedures, mortality, and costs.

As key opinion leaders, Certara’s real world data specialists speak regularly at international industry events and have significant communication and publication records.

お問合せ

Generate evidence to quantify opportunity and justify access

ヨーロッパの実世界のデータソースの中で、フランスのヘルスケアデータベースSNDSは、最大かつ最も包括的なヘルスケアデータリソースであり、フランス人口の99%以上、ヨーロッパの10％程度に相当する...

Drawing on decades of experience in real-world studies and renowned expertise in SNDS, we offer solutions for every need: ニッチな需要の特定、アクセスの正当化、価値の差別化、機会の定量化から、効果/リスクの実証まであらゆるニーズに対応するリアルワールド・データ・ソリューションを提供します

機会の定量化：アンメット・ニーズ、治療パターン、疾病負担、市場サイジング
アクセスの正当性：Cost minimization, cost offsets, cost effectiveness and budget impact analysis
パフォーマンスの測定：Drug utilization studies, relative effectiveness, outcomes performance, PAES
安全性の確保：Benefit/risk assessment, risk management, signal detection, PASS

Quantify outcomes with patient and population-based research

Certara’s research has been instrumental in demonstrating the benefit that products and health technologies provide to patients. Certara offers real world data solutions for every need and SNDS represents a substantial part of it. Our SNDS studies are trusted by leading innovators to identify treatment patterns and patient outcomes, unmet needs among niche patient groups to target drugs, as well as burden of illness and resource utilization in the real world.

カタログダウンロード

Quantify outcomes with patient and population-based research

Unmatched quality in data and analysis

Certara experts pioneered the use of electronic health care databases (EHCD) and electronic Medical Records (EMR) for conducting pharmaco-epidemiology studies. Our unique services link observational studies to advanced modeling in access data platforms built for bridging-to-real life studies.

Many of the typical challenges associated with conducting research using claims data can be addressed with appropriate study design and analysis using SNDS. The SNDS coverage (almost all people living in France), its universal nature and its size allow to minimize biases, long follow-up time (~10 years) and make it suitable for studying small patient populations, which is helpful when doing research on rare diseases and drug-related adverse events.

まずはご相談ください